Atlas Trials

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Clinical trial NCT03553238 · UNKNOWN

Trial details

NCT number
NCT03553238
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Leukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic
Start date
2016-02-14
Primary completion
2020-05-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.